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Abstract 
D-dimer  levels  in  plasma,  a  degradation
product of fibrin, have been shown to correlate
with the severity of ischemic stroke. In order to
investigate the outcome of patients with ele-
vated D-dimer we have carried out a follow-up
study  of  patients  of  65  years  of  age  and
younger with acute ischemic stroke or tran-
sient ischemic attacks (TIA) admitted to our
stroke unit from 1991 to 1992. Twenty-two of
the 57 patients had elevated D-dimer levels in
the plasma. High levels were associated with
cardioembolic  stroke.  On  follow-up  after  a
mean of 12 years, 15 patients had died and six
patients  had  suffered  another  stroke  or  TIA
(three of whom were dead). Ten patients had
suffered other cardiovascular events and seven
of them were dead. We concluded that high lev-
els  of  D-dimer  in  acute  ischemic  stroke
patients  on  admission  were  associated  with
cardioembolic stroke and might have prognos-
tic value for the development of further cardio-
or cerebrovascular events. Advanced age was
found to be an independent risk factor.
Introduction 
Hematologic abnormalities appeared to be
the main cause of ischemic stroke in approxi-
mately one percent of all cases, and derange-
ment of the coagulation process in young peo-
ple with stroke has been estimated to be about
four percent.
1 The most studied factors in the
coagulation  process  are  anticardiolipin  anti-
bodies (ACA), which have been recognized as
markers for an increased risk of thrombosis,
and  cerebral  ischemia.
2 Previously  we  have
shown an association between protein S defi-
ciency  and  elevated  ACA.
3 D-dimer  levels  in
plasma, a degradation product of fibrin, have
been  shown  to  correlate  with  severity  of
ischemic stroke
4 and clinical progression.
5 We
prospectively  investigated  all  acute  stroke
patients of 65 years of age and younger admit-
ted to our stroke unit between 1991 and 1992
for  traditional  risk  factors  and  D-dimer.  In
order to study the outcome and long-term fol-
low-up a questionnaire concerning cerebro- or
cardioischemic events was sent to all patients
during  spring  2004  (n=42).  Patients  not
responding to the written questionnaire were
contacted by phone. In addition, the medical
records  from  the  departments  of  Neurology
and  Internal  Medicine  were  checked  for  all
patients.
Materials and Methods 
Patients 
With  the  approval  for  this  study  by  the
ethics  committee  of  Linköping  University
Hospital, 502 patients, who were admitted to
our stroke unit for suspected acute stroke dur-
ing 1991 to 1992, were investigated for the
presence of ACA.
6 Three hundred and ninety-
four of the 502 patients of all age groups had
ischemic stroke or transient ischemic attacks
(TIA).  In  66  patients  of  65  years  of  age  or
younger ACA, protein C and S, free protein S,
and ATIII were analysed.
3 In 57 of these 66
patients (36 men and 21 women, mean age
51.4 yr, range 24-64 yr), D-dimer was meas-
ured as well. Blood samples were taken within
24  hours  of  admission  in  the  patients.  All
patients underwent computed tomography of
the brain to establish diagnosis. Strokes were
classified on the basis of the presence of risk
factors, the mode of onset, clinical findings,
and the nature and location of the occluded
vessel according to Berger et al.
7 (cardioem-
bolic: n=11, atherothrombotic: n=11, lacunar:
n=19, TIA: n=11, unknown: n=5). In addition,
previous  stroke,  myocardial  infarction,  and
peripheral thrombosis were noted. Symptoms
and laboratory signs of infection were record-
ed.  Platelet  count,  activated  partial  trombo-
plastin time (APTT), sedimentation rate (SR),
C-reactive protein (CRP), and white blood cell
count were measured in all patients. Risk fac-
tors were scrutinized in each patient. Carotid
Doppler  was  performed  in  49  patients.
Triglycerides and cholesterol were examined
in 50 patients. 
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Figure 1. D-dimer levels in relation to stroke subtypes. 
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D-dimer  was  measured  utilizing  an  auto-
mated  micro-latex  assay,  Tina-quant
®,  from
Boehringer-Mannheim (Darmstadt, Germany)
using a Hitachi 911 analyzer, manufactured by
Hitachi  (Kobe,  Japan).  Normal  values  were
<0.15 mg/mL, which was the lower detection
limit.
Statistical methods
Student’s t-test was used for analyses of D-
dimer levels in relation to the type of stroke.
The  ˇ
2-test  was  used  to  compare  groups  of
patients with elevated or normal D-dimer lev-
els. A multivariate logistic regression analysis
was used to compare risk factors in patients
with  later  cerebro-  or  cardiovascular  events
compared  to  patients  without  later  events. 
A p-value of ≤0.05 was judged as significant.
Results 
Elevated D-dimer levels were found in 22 of
the 57 patients (mean 0.41 mg/mL, range 0.15-
2.02) (Table 1). One of the patients had a pre-
vious  TIA  and  one  a  myocardial  infarction.
Three patients were found to have a carotid
stenosis of ≥75% and two a carotid occlusion.
We found significantly elevated D-dimer levels
in  cardioembolic  stroke  as  compared  to
atherothrombotic and lacunar stroke (Figure
1).  There  were  more  patients  with  a  major
than a minor stroke in the group with elevated
D-dimer levels (9/13) compared to the group
with normal D-dimer levels (8/27), although
this difference was not statistically significant
(p=0.15, ˇ
2-test) (Table 1). The mean value for
patients  with  major  stroke  was  0.47  mg/mL
(range 0.15-2.02) compared to patients with
minor stroke: 0.36 mg/mL (range 0.16-1.42),
not a statistically significant difference. On fol-
low-up after a mean of 12 years, 15 patients
had died (seven from cardiovascular events,
three from pneumonia, two from cancer, one
after a pulmonary embolus, one from amyloi-
dosis, and one from multi-organ failure). Five
patients had suffered another ischemic stroke
(three of whom were dead) and one had suf-
fered a TIA. Ten had suffered other cardiovas-
cular  events  (myocardial  infarction,  angina,
congestive  heart  failure,  aortic  aneurysm),
seven of them were dead (Figure 2). 
There was a trend for patients with elevated
levels of D-dimer at the time of sampling after
the stroke to be more prone to develop further
cardio- or cerebrovascular events at follow-up
(eight of 22 patients compared to seven of 35
of those with normal D-dimer levels; p=0.17,
ˇ
2-test and Pearson’s correction). Mean values
were slightly higher for patients who had fur-
ther cardio- and cerebrovascular events: 0.47
mg/mL  (range  0.19-1.42)  compared  to  0.37
mg/mL (range 0.15-2.02) for those without fur-
ther  events  during  follow-up.  When  using  a
multivariate analysis with logistic regression,
however, this variable was not an independent
risk  factor  (odds  ratio  2.5,  p=0.19).  The  15
patients with later cerebro- or cardiovascular
events  were  significantly  older:  60.4  years
compared  to  the  42  patients  without  later
events aged 49.5 years (odds ratio 1.2, p=0.01).
Other  risk  factors  (cardiac  arrhythmia,  dia-
betes,  high  blood  pressure,  carotid  stenosis,
smoking,  high  cholesterol,  previous  TIA  or
stroke, or angina) were not independently cor-
related  to  later  cerebro-  or  cardiovascular
events.
Discussion 
We found an association between elevated
D-dimer  levels  and  cardioembolic  stroke,
which was in agreement with reports of other
researchers.
4,8 Elevated levels in patients with
acute ischemic stroke have been found for up
to four weeks in some persons.
9 In addition,
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Table 1. Characteristics of patients with elevated and normal D-dimer levels.
Patient  Number and  Age, years Atrial Diabetes Hypertension Carotid Doppler Major/ Subtype Infectious
group sex (male/ (mean  fibrillation mellitus (stenosis ≥75%  minor  of stroke parameters
female) and range) or occlusion) stroke (number  (number of
of patients) elevated tests)
Elevated 22  52.3 026 5 9/13 cardioembolic 4 SR 7
D-dimer  (14/8) (30-65) atherothrombotic 7 CRP 3
levels lacunar 8 WBC 8
unknown 1
TIA 2
Normal  35  52.3 3411 0 8/27 cardioembolic 7 SR 5
D-dimer (21/14) (25-65) atherothrombotic 4 CRP 4
levels lacunar 11 WBC 8
unknown 4
TIA 9
SR: sedimentation rate (n<20 mm for men and <12 mm for women), CRP: C-reactive protein (n<10), WBC: white blood cell count (n<10x10
9/L).
Figure 2. Kaplan-Meyer graph of cerebro- and cardiovascular events during follow-up.
MI: myocardial infarction; CI: cerebral infarction; TIA: transitory ischemic attack; †: dead.
57
56
55
54
53
52
51
50
49
48
47
46
45
44
43
92 93 94 95 96 97 98 99 00 01 02 03 04 Year
MI †
Congestive heart failure †
CI (died in -96 in MI) 
Pulmonary embolus †
Angina
CI
MI †
2 MI †
MI †
CI
2 CI (one died of pneumonia in 2001 and 
one of aortic aneurysm in 2002)plasma concentrations of D-dimer have been
reported  to  be  an  indicator  of  recurrent
embolization  in  patients  suffering  from  car-
dioembolic  stroke.
10 A  trend  toward  an
increased risk of recurrent cardio- and cere-
brovascular events on follow-up after a mean of
12 years in patients with elevated D-dimer lev-
els was noted (eight of 22 patients compared to
seven of 35 with normal D-dimer levels); how-
ever, the difference was not statistically signif-
icant  (p=0.17).  Patients  with  high  D-dimer,
fibrinogen, and CRP have been associated with
an increased risk of recurrent cardiovascular
events,
11 which was found in our patients with
elevated D-dimer levels (10 had suffered car-
diovascular events on follow-up). 
In  a  review,  Lowe  (2005)
12 discussed  the
potential clinical utility of D-dimer testing in
the prediction of cardiovascular risk and pro-
phylactic anticoagulation. In addition, D-dimer
levels have been shown to predict clinical pro-
gression in ischemic stroke.
5 There are further
reports  showing  no  relationship  between  D-
dimer levels and recurrent ischemic stroke.
13,14
Woodward et al.,
14 however, found that fibrino-
gen and CRP were risk factors for recurrent
ischemic stroke. The severity of the recurrent
events in our patients is evident because five
of the eight patients died. D-dimer levels were
found to be related linearly to stroke severity in
76  consecutive  ischemic  stroke  patients.
15
Moreover, D-dimer is reported to be a good pre-
dictor for identifying patients at high risk for
stroke progression, supporting our observation
of a severe course for many of the patients
with  elevated  D-dimer  levels.
5 Patients  with
atrial fibrillation and elevated D-dimer levels
are  reported  to  be  more  prone  to  develop
thromboembolic  events.
16 This  conclusion  is
disputed by others.
17 In our patients with ele-
vated D-dimer levels, none of them had atrial
fibrillation. However, high-grade carotid steno-
sis (≥75%) or carotid occlusion was found in
five of our patients with elevated D-dimer lev-
els. We concluded that high levels of D-dimer
in  patients  with  acute  ischemic  stroke  are
associated with cardioembolic stroke and may
have a pathogenetic importance for develop-
ment  of  further  cardio-  or  cerebrovascular
events. Advanced age seems to be an important
independent risk factor for further cerebro- or
cardiovascular events. Because there were rel-
atively few patients in our study, its prognostic
role remains somewhat uncertain and, as sug-
gested by Squizzato et al.
18 further larger stud-
ies are warranted. 
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